Preview: Camp4 Therapeutics Corporation Set To IPO Tomorrow
Preview: Camp4 Therapeutics Corporation Set To IPO Tomorrow
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases.CAMP4 Therapeutics Corporation (NASDAQ:CAMP) IPO will take place October, 11 on the NASDAQ exchange under the ticker CAMP.
CAMP4 Therapeutics 公司 (纳斯达克代码：CAMP) 的首次公开募股将于10月11日在纳斯达克交易所进行，股票代码为 CAMP。
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on April 09, 2025.
该公司正在以每股14.00美元至16.00美元的预期价格提供股份，内部限售期为180天，截至2025年4月09日。
See also: Benzinga IPO Calendar
参见：Benzinga IPO日历
About CAMP4 Therapeutics Corporation
关于 CAMP4 Therapeutics 公司
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases.
CAMP4 Therapeutics 公司是一家临床阶段生物制药公司，开拓性地发现和开发基于调节 RNA 的治疗药物，旨在上调基因表达并恢复健康蛋白水平，以治疗广泛的遗传性疾病。
See also: Benzinga's Most Shorted Stocks
参见：Benzinga的做空集合股
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动化内容引擎生成并由编辑审查。
